We are live on ! Find out more
TCM

Tao Capital Management Portfolio holdings

AUM $119M
1-Year Est. Return 87.46%
This Fund
S&P 500
This Quarter Est. Return
+19.15%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
–
AUM
$132M
AUM Growth
-$4.17M
Cap. Flow
-$24M
Cap. Flow %
-18.18%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$2.75M

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$26.8M

Sector Composition

Rank Sector Weight
1 Healthcare 40.37%
2 Consumer Discretionary 36.61%
3 Technology 23.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
1
Tesla
TSLA
$1.22T
$38.4M 29.01%
86,250
– –
OUST icon
2
Ouster
OUST
$2.3B
$30.4M 23.03%
1,125,316
– –
TWST icon
3
Twist Bioscience
TWST
$5.33B
$23.3M 17.64%
828,815
– –
MDGL icon
4
Madrigal Pharmaceuticals
MDGL
$12.8B
$18.8M 14.22%
41,000
-71,785
-64% -$26.8M
H icon
5
Hyatt Hotels
H
$17.8B
$9.94M 7.52%
70,000
– –
MASS icon
6
908 Devices
MASS
$288M
$4.98M 3.77%
568,981
– –
WRBY icon
7
Warby Parker
WRBY
$3.06B
$3.71M 2.81%
134,473
– –
TXG icon
8
10x Genomics
TXG
$5.82B
$2.46M 1.86%
+210,862
New +$2.75M
SOND
9
DELISTED
Sonder
SOND
$102K 0.08%
80,188
– –
DNA icon
10
Ginkgo Bioworks
DNA
$483M
$82.9K 0.06%
5,683
– –

Similar funds

SF
Schaeffer Financial Rockville, Maryland $119M AUM 12.28% 1-Year Est. Return
MWM
McCartney Wealth Management Clayton, Missouri $119M AUM
VA
Valor Advisors Miami, Florida $119M AUM
HPM
Hudson Portfolio Management Garrison, New York $119M AUM 24.19% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
WKSWA
White Knight Strategic Wealth Advisors Princeton, New Jersey $119M AUM 24.94% 1-Year Est. Return
CA
Commerce Advisors Memphis, Tennessee $119M AUM
LC
Lubar & Co Milwaukee, Wisconsin $119M AUM

Tao Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Tao Capital Management held 10 positions worth $132M, down 3.1% from $136M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tao Capital Management withdrew a net $24M in Q3 2025, reducing 1 holding. Its largest reduction was Madrigal Pharmaceuticals, cutting an estimated $26.8M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 53% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Tao Capital Management opened a new position in 10x Genomics worth $2.46M.

  • Tao Capital Management's largest Q3 2025 buy was 10x Genomics: 210,862 shares worth $2.46M.
  • Tao Capital Management's biggest Q3 2025 reduction was Madrigal Pharmaceuticals, cutting an estimated $26.8M.
  • Tao Capital Management's ten largest holdings make up 100% of its $132M portfolio in Q3 2025.
  • Tao Capital Management opened 1 new position and closed 0 in Q3 2025.
  • Tao Capital Management's portfolio value fell 3.1% quarter-over-quarter to $132M.

Based on Tao Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.